Standalone Trabeculotomy and Viscodilation used in Open-Angl
Now open: Certificate Course in Management of Covid-19 by Govt. Of Gujarat and PlexusMDKnow more...Now open: Certificate Course in Management of Covid-19 by Govt. Of Gujarat and PlexusMDKnow more...
Researchers aimed to find the Intraocular pressure (IOP), medication outcomes at 24 months following trabeculotomy/viscodilation using the OMNI® surgical system as a standalone procedure in medically uncontrolled mild–moderate open-angle glaucoma (OAG).

IOP and medication data were collected before surgery and through 24 months. Safety data included adverse events and the need for additional surgery.

Results:
--This analysis included data from 38 eyes of 27 subjects. Mean (standard deviation) baseline IOP was 24.6 mmHg and through 24 months ranged from 12.6 to 14.9 mmHg, representing reductions of 10.0– 12.0 mmHg.

--Mean medications were 1.9 and through 24 months ranged from 0.0 to 0.5.

--At Month 24, mean IOP was 14.9 mmHg, and 100% of eyes achieved IOP reduction more than 20% from baseline; mean medication use was 0.5, 84.6% of eyes using more than 1 fewer medication, and 57.7% were medication-free.

--The most common adverse event was intraoperative hyphema (44.7%); all resolved spontaneously. There were two secondary procedures for IOP control.

In conclusion, both IOP and drugs with an outstanding safety profile are subject to clinically relevant and statistically important reductions, which are phakic or pseudophakic in the eye with mild-moderate OAG, which require IOP or medication reduction or both.

Source: https://www.dovepress.com/standalone-trabeculotomy-and-viscodilation-of-schlemms-canal-and-colle-peer-reviewed-fulltext-article-OPTH
Like
Comment
Share